• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

干扰素与多发性硬化症

Interferons and multiple sclerosis.

作者信息

Clanet M, Blancher A, Calvas P, Rascol O

机构信息

Service de Neurologie, CHU Purpan, Toulouse, France.

出版信息

Biomed Pharmacother. 1989;43(5):355-60. doi: 10.1016/0753-3322(89)90061-9.

DOI:10.1016/0753-3322(89)90061-9
PMID:2477075
Abstract

Interferons (IFNs) are a family of proteins with antiviral, antitumoral and immunomodulating properties. Multiple Sclerosis (MS) is a CNS disease in which the immune reaction (IR) is the cause of the inflammatory demyelinating lesions. IFNs have been demonstrated in active lesions. The location of IFN gamma on astrocytes suggests an enhancing activity on IR by inducing Ia antigen expression on these cells. In contrast, IFN alpha/beta located on microglial cells and astrocytes might limit the growing lesion. MS patients frequently present a defective response of NK cell activity and an abnormally low production of IFNs reflecting immune dysregulation. The therapeutic trials available to date are discussed: IFN gamma possesses a severe deleterious effect but IFN alpha/beta are still under consideration due to a possible beneficial activity.

摘要

干扰素(IFNs)是一类具有抗病毒、抗肿瘤和免疫调节特性的蛋白质。多发性硬化症(MS)是一种中枢神经系统疾病,其中免疫反应(IR)是炎症性脱髓鞘病变的病因。在活跃病变中已证实存在干扰素。γ干扰素在星形胶质细胞上的定位表明,通过诱导这些细胞上Ia抗原的表达,对免疫反应具有增强活性。相比之下,位于小胶质细胞和星形胶质细胞上的α/β干扰素可能会限制病变的发展。MS患者经常出现自然杀伤细胞活性反应缺陷以及反映免疫失调的干扰素产生异常低下的情况。本文讨论了迄今为止可用的治疗试验:γ干扰素具有严重的有害作用,但α/β干扰素由于可能具有有益活性仍在考虑之中。

相似文献

1
Interferons and multiple sclerosis.干扰素与多发性硬化症
Biomed Pharmacother. 1989;43(5):355-60. doi: 10.1016/0753-3322(89)90061-9.
2
Multiple sclerosis: involvement of interferons in lesion pathogenesis.
Ann Neurol. 1988 Aug;24(2):243-51. doi: 10.1002/ana.410240211.
3
Interferons in multiple sclerosis. A review of the evidence.干扰素与多发性硬化症。证据综述。
Drugs. 1992 Dec;44(6):946-62. doi: 10.2165/00003495-199244060-00004.
4
Systemic interferon therapy for multiple sclerosis. Design of a trial.用于多发性硬化症的全身干扰素治疗。一项试验的设计。
Arch Neurol. 1983 Oct 21;40(11):681-2. doi: 10.1001/archneur.1983.04050100021007.
5
Biologic effects of interferons: relevance to multiple sclerosis.干扰素的生物学效应:与多发性硬化症的相关性。
Mult Scler. 1995;1 Suppl 1:S12-6.
6
Evaluation of antiviral effect of type I, II, and III interferons on direct-acting antiviral-resistant hepatitis C virus.评价 I、II 和 III 型干扰素对直接作用抗病毒药物耐药性丙型肝炎病毒的抗病毒效果。
Antiviral Res. 2017 Oct;146:130-138. doi: 10.1016/j.antiviral.2017.08.017. Epub 2017 Aug 31.
7
Interferon-gamma and Ia antigen are present on astrocytes in active chronic multiple sclerosis lesions.
J Neurol Sci. 1988 Apr;84(2-3):257-64. doi: 10.1016/0022-510x(88)90130-x.
8
Effect of rat and beta-human interferons on hyperacute experimental allergic encephalomyelitis in rats.
Agents Actions. 1985 Jul;16(5):397-403. doi: 10.1007/BF01982879.
9
How type I interferons work in multiple sclerosis and other diseases: some unexpected mechanisms.I型干扰素在多发性硬化症及其他疾病中的作用机制:一些意想不到的机制
J Interferon Cytokine Res. 2014 Aug;34(8):589-99. doi: 10.1089/jir.2013.0158.
10
Drug Insight: interferon treatment in multiple sclerosis.药物洞察:多发性硬化症的干扰素治疗
Nat Clin Pract Neurol. 2006 Jan;2(1):34-44. doi: 10.1038/ncpneuro0088.

引用本文的文献

1
Comparative transcriptome profiling of the lumbosacral dorsal root ganglia reveals sexually dimorphic gene expression in a murine model of coronavirus-induced neurodegeneration.腰骶背根神经节的比较转录组分析揭示了冠状病毒诱导的神经退行性变小鼠模型中的性别二态性基因表达。
Am J Clin Exp Urol. 2025 Jun 15;13(3):194-214. doi: 10.62347/SLKE7419. eCollection 2025.
2
The role of IFN-γ production during retroviral infections: an important cytokine involved in chronic inflammation and pathogenesis.γ-干扰素在逆转录病毒感染中的作用:一种参与慢性炎症和发病机制的重要细胞因子。
Rev Inst Med Trop Sao Paulo. 2022 Sep 30;64:e64. doi: 10.1590/S1678-9946202264064. eCollection 2022.
3
Clinical toxicity of the interferons.
Drug Saf. 1994 Feb;10(2):115-50. doi: 10.2165/00002018-199410020-00003.